ImaginAb Secures $21,000,000 Series B Financing Round

  • Feed Type
  • Date
    5/9/2014
  • Company Name
    ImaginAb
  • Mailing Address
    423 Hindry Ave. Inglewood, CA 90301 USA
  • Company Description
    ImaginAb’s mission is to transform the clinical management of cancer and autoimmune diseases via targeted molecular imaging. We re-engineer therapeutic antibodies against biologically important targets into small proteins optimized for diagnostic imaging with Positron Emission Tomography (PET).
  • Website
    http://www.imaginab.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $21,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    We have made excellent progress with our programs in cancer and immunology, and we are pleased to have concluded this round of growth capital to accelerate the development of IAB2M, our lead program in prostate cancer, and continue to expand our product pipeline.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor